These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19652455)

  • 1. Effects of acute intravenous administration of pentamidine, a typical hERG-trafficking inhibitor, on the cardiac repolarization process of halothane-anesthetized dogs.
    Yokoyama H; Nakamura Y; Iwasaki H; Nagayama Y; Hoshiai K; Mitsumori Y; Sugiyama A
    J Pharmacol Sci; 2009 Aug; 110(4):476-82. PubMed ID: 19652455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of cardiohemodynamic and electrophysiological effects of morphine along with its toxicokinetic profile using the halothane-anesthetized dogs.
    Goto A; Kambayashi R; Fujishiro M; Hasegawa C; Izumi-Nakaseko H; Takei Y; Kurosaki K; Sugiyama A
    J Toxicol Sci; 2024; 49(6):269-279. PubMed ID: 38825486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiohemodynamic and electrophysiological effects of a selective EP4 receptor agonist ONO--AE1--329 in the halothane-anesthetized dogs.
    Nomura H; Nakamura Y; Cao X; Honda A; Katagi J; Ohara H; Izumi-Nakaseko H; Satoh Y; Ando K; Sugiyama A
    Eur J Pharmacol; 2015 Aug; 761():217-25. PubMed ID: 26073024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentamidine reduces hERG expression to prolong the QT interval.
    Cordes JS; Sun Z; Lloyd DB; Bradley JA; Opsahl AC; Tengowski MW; Chen X; Zhou J
    Br J Pharmacol; 2005 May; 145(1):15-23. PubMed ID: 15711592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electropharmacological effects of a spironolactone derivative, potassium canrenoate, assessed in the halothane-anesthetized canine model.
    Sugiyama A; Satoh Y; Takahara A; Ando K; Wang K; Honsho S; Nakamura Y; Hashimoto K
    J Pharmacol Sci; 2004 Dec; 96(4):436-43. PubMed ID: 15599107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic modulation of HERG potassium channels by the volatile anesthetic halothane.
    Li J; Correa AM
    Anesthesiology; 2002 Oct; 97(4):921-30. PubMed ID: 12357160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Safety Margin of Lithium Carbonate Against Cardiovascular Adverse Events Assessed in the Halothane-Anesthetized Dogs.
    Goto A; Nakamura Y; Lubna NJ; Chiba K; Hagiwara-Nagasawa M; Izumi-Nakaseko H; Ando K; Naito AT; Sugiyama A
    Cardiovasc Toxicol; 2018 Dec; 18(6):530-536. PubMed ID: 29845450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular determinants of pentamidine-induced hERG trafficking inhibition.
    Dennis AT; Wang L; Wan H; Nassal D; Deschenes I; Ficker E
    Mol Pharmacol; 2012 Feb; 81(2):198-209. PubMed ID: 22046004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electropharmacological effects of amantadine on cardiovascular system assessed with J-Tpeak and Tpeak-Tend analysis in the halothane-anesthetized beagle dogs.
    Cao X; Nakamura Y; Wada T; Izumi-Nakaseko H; Ando K; Sugiyama A
    J Toxicol Sci; 2016; 41(3):439-47. PubMed ID: 27193735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentamidine-induced long QT syndrome and block of hERG trafficking.
    Kuryshev YA; Ficker E; Wang L; Hawryluk P; Dennis AT; Wible BA; Brown AM; Kang J; Chen XL; Sawamura K; Reynolds W; Rampe D
    J Pharmacol Exp Ther; 2005 Jan; 312(1):316-23. PubMed ID: 15340016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac and haemodynamic effects of tacrolimus in the halothane-anaesthetized dog.
    Kise H; Nakamura Y; Hoshiai M; Sugiyama H; Sugita K; Sugiyama A
    Basic Clin Pharmacol Toxicol; 2010 Apr; 106(4):288-95. PubMed ID: 19912168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiological evaluation of pentamidine and 17-AAG in human stem cell-derived cardiomyocytes for safety assessment.
    Asahi Y; Nomura F; Abe Y; Doi M; Sakakura T; Takasuna K; Yasuda K
    Eur J Pharmacol; 2019 Jan; 842():221-230. PubMed ID: 30391349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electropharmacological Characterization of Aciclovir in the Halothane-Anesthetized Dogs: A Proposal of Evaluation Method for Cardiovascular Safety Pharmacology of Anti-virus Drugs.
    Kondo Y; Hagiwara-Nagasawa M; Kambayashi R; Goto A; Chiba K; Nunoi Y; Izumi-Nakaseko H; Matsumoto A; Sugiyama A
    Cardiovasc Toxicol; 2020 Aug; 20(4):419-426. PubMed ID: 32193875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of lysosomal degradation rescues pentamidine-mediated decreases of K(IR)2.1 ion channel expression but not that of K(v)11.1.
    Nalos L; de Boer TP; Houtman MJ; Rook MB; Vos MA; van der Heyden MA
    Eur J Pharmacol; 2011 Feb; 652(1-3):96-103. PubMed ID: 21114988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiohemodynamic and Arrhythmogenic Effects of the Anti-Atrial Fibrillatory Compound Vanoxerine in Halothane-Anesthetized Dogs.
    Hagiwara-Nagasawa M; Kambayashi R; Goto A; Nunoi Y; Izumi-Nakaseko H; Takei Y; Matsumoto A; Sugiyama A
    Cardiovasc Toxicol; 2021 Mar; 21(3):206-215. PubMed ID: 33074476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the electropharmacological effects of verapamil and propranolol in the halothane-anesthetized in vivo canine model under monophasic action potential monitoring.
    Shiina H; Sugiyama A; Takahara A; Satoh Y; Hashimoto K
    Jpn Circ J; 2000 Oct; 64(10):777-82. PubMed ID: 11059619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein trafficking abnormalities: a new mechanism in drug-induced long QT syndrome.
    Eckhardt LL; Rajamani S; January CT
    Br J Pharmacol; 2005 May; 145(1):3-4. PubMed ID: 15711590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Halothane sensitizes the canine heart to pharmacological IKr blockade.
    Takahara A; Sugiyama A; Satoh Y; Wang K; Honsho S; Hashimoto K
    Eur J Pharmacol; 2005 Jan; 507(1-3):169-77. PubMed ID: 15659307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo analysis of acute eletropharmacological effects of proton pump inhibitors using halothane-anesthetized dogs: a translational study of cardiovascular adverse events.
    Kambayashi R; Goto A; Izumi-Nakaseko H; Takei Y; Sugiyama A
    J Toxicol Sci; 2023; 48(7):375-385. PubMed ID: 37394651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular effects of Y-27632, a selective Rho-associated kinase inhibitor, assessed in the halothane-anesthetized canine model.
    Takahara A; Sugiyama A; Satoh Y; Yoneyama M; Hashimoto K
    Eur J Pharmacol; 2003 Jan; 460(1):51-7. PubMed ID: 12535859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.